James Allen Helliwell, Chief Executive Officer at Eupraxia Pharmaceuticals, holds 674.01K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, James Allen Helliwell Bought C$14,286 shares of Eupraxia Pharmaceuticals on Aug 21, 2023 for an estimated value of 100.00K.
What is the percentage of profitable transactions made by James Allen Helliwell?
The percentage of profitable transactions made by James Allen Helliwell is 80%.
What is the average return per transaction made by James Allen Helliwell?
The average return per transaction made by James Allen Helliwell is 319.90%.
What stocks does James Allen Helliwell hold?
James Allen Helliwell holds: TSE:EPRX stocks.
What was James Allen Helliwell’s latest transaction?
James Allen Helliwell latest transaction was an Informative Buy of C$100.00K.
What was James Allen Helliwell's most profitable transaction?
James Allen Helliwell’s most profitable transaction was an Informative Buy of TSE:EPRX stock on July 4, 2022. The return on the trade was 759.20%.
What is James Allen Helliwell's role in Eupraxia Pharmaceuticals?
James Allen Helliwell's role in Eupraxia Pharmaceuticals is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.